Publications
- Anticancer drug ellipticine forms DNA adducts in vivo; A novel mode of its antineoplatic action2004 | First Faculty of Medicine, Faculty of Mathematics and Physics
- The anticancer drug ellipticine forms covalent DNA adducts, mediated by human cytochromes P450, through metabolism to 13-hydroxyellipticine and ellipticine N-2-oxide2004 | First Faculty of Medicine, Faculty of Mathematics and Physics
- ANTICANCER DRUG ELLIPTICINE ACTS AS AN INDUCER OF CYTOCHROMES P450 1A1/2 AND POTENTIATES ITS OWN PHARMACOLOGICAL EFFICIENCY2003 | First Faculty of Medicine, Faculty of Mathematics and Physics
- The anticancer drug ellipticine acts as an inducer of cytochromes P450 1A1/2 and potentiates its own pharmacological efficiency2003 | First Faculty of Medicine, Faculty of Mathematics and Physics
- The interaction between the anticancer drug ellipticine and cytochromes P450 dictates its pharmacological efficiencies2003 | First Faculty of Medicine, Faculty of Mathematics and Physics
- Induction of cytochromes P450 1A1/2 by the anticancer drug ellipticine2003 | First Faculty of Medicine, Faculty of Mathematics and Physics
- DNA adduct formation by the anticancer drug ellipticine in rats determined by 32P-postlabeling2003 | First Faculty of Medicine, Faculty of Mathematics and Physics
- Interaction of anticancer drug ellipticine with cytochromes P4502002 | First Faculty of Medicine, Faculty of Mathematics and Physics
- Interaction of anticancer drug elliptcine with cytochromes P450 dictates its physiological properties2002 | First Faculty of Medicine, Faculty of Mathematics and Physics
- Interaction of anticancer drug ellipticine with cytochrome P4502001 | First Faculty of Medicine, Faculty of Mathematics and Physics
Loading network view...